Carla Mouta-Bellum
Carla Mouta-Bellum
is an IP Attorney with Arrigo, Lee, Guttman & Mouta-Bellum, whose practice focuses on the combination of biotechnology and pharmaceuticals with diagnostics as the basis for the success of Personalized Medicine approaches and the future of medical treatment, including immunotherapy. As both an experienced scientist and IP attorney, Carla has worked closely with many academic scientists and companies in these fields and has more than 12 years of experience developing strong and diverse patent portfolios and counseling clients in IP matters.
For more information, or to Contact Dr. Mouta-Bellum, please visit her Firm Profile Page.
Posts by Carla Mouta-Bellum
Patenting Antibodies: Obviousness Considerations
This article analyzes obviousness issues related to antibody patents at the Patent Trials and Appeal Board (PTAB) and in federal courts. We review several cases categorized by …
The Immunotherapy Patent Landscape: Types of patent claims for immunotherapeutic inventions
Immunotherapy has emerged as one of the most promising mechanisms to combat diseases like cancer and microbial infections. Since 2000, multiple antibody drugs have reached blockbuster status, including …
